查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
合成小分子 API 的市場規模、份額和趨勢分析報告：按製造商（內部、外包）、應用（心血管、癌症）、地區、細分市場預測，2022-2030
市場調查報告書
商品編碼
1133274

合成小分子 API 的市場規模、份額和趨勢分析報告：按製造商（內部、外包）、應用（心血管、癌症）、地區、細分市場預測，2022-2030

Synthetic Small Molecule API Market Size, Share & Trends Analysis Report By Manufacturer (In-house, Outsourced), By Application (Cardiology, Oncology), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

合成小分子 API 市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年，全球合成小分子 API 市場規模預計將達到 2171.7 億美元。預計從 2022 年到 2030 年，市場的複合年增長率為 5.73%。這是由於全球對藥品和新型小分子藥物的需求不斷增長。此外，跨劑型的小分子 API 的多功能性和易於純化使其更易於接受和需求。

在製藥行業，合成藥物的比例正在增加，預計這將增加對小分子原料藥等生產所需原材料的需求。此外，與增強現有產品相關的技術進步有望為小分子療法提供新的機會。例如，2022年3月，贏創推出了一項增強口服小分子溶解度的新技術：EUDRATECSoluFlow。

市場受到每個地區政府對 API 生產的積極支持的推動，尤其是在亞洲，大多數 API 製造商依賴 API 供應來生產合成小分子 API。.原料藥製造的外包活動也越來越受到關注。例如，2020 年 4 月，為了管理 COVID-19，Wavelength Pharmaceuticals 擴大了對呼吸系統重症患者管理所需的某些藥物的關鍵活性成分的供應，並推出了 API CDMO 服務。中國、印度和東南亞等新興市場代表著巨大的增長機會。

由於亞洲製造商專注於可大規模生產的低複雜性分子，因此對新技術和復雜技術的投資仍然相對較低。因此，投資高收益、低成本的技術是歐洲、北美等其他發達地區製造商規避競爭壓力的一種選擇。

市場上的主要參與者都專注於合作生產功能強大的 API 產品。例如，2021 年 8 月，Almac Sciences 與 Pila Pharma 就生產 API XEN-D0501（一種高活性和選擇性的小分子 TRPV1 拮抗劑）達成協議。此外，CDMO 通過擴展其能力來不斷發展，以滿足對合成藥物日益增長的需求。例如，2022 年 4 月，AGC Inc. 宣布擴建 7500 平方米的西班牙合成藥物生產設施，預計這將提振該地區對合成小分子 API 的需求。

合成小分子 API 市場報告亮點

整體市場的增長是由於對原材料的需求增加導致藥品產量增加。

API 市場正在經歷一個重要的轉折點，越來越傾向於使用 CDMO 大規模生產合成小分子 API

按製造商劃分，由於中小企業依賴外包進行商業生產，預計外包行業在預測期內將顯著增長

2021 年的市場細分以心血管領域為主。這是由於目標疾病的患病率越來越高

由於主要參與者的存在以及政府為提高該地區 API 製造能力而增加的政府支持，北美在 2021 年主導了市場

目錄

u>

H3>

第 1 章合成小分子 API 市場：研究方法和範圍

  • 市場細分
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法按國家/地區進行市場預測
      • 方法 2：使用自上而下的方法估算各國市場
  • 全球市場：CAGR 計算
  • 區域市場：CAGR 計算
  • 二級信息列表
  • 目的
  • 縮寫列表

第 2 章。合成小分子 API 市場：執行摘要

  • 合成小分子 API 市場：市場展望
    • 市場概覽

第 3 章。合成小分子 API 市場：行業展望

  • 市場系列展望
    • 母市場譜系預測
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力
      • 醫藥行業高速增長
      • 增加新分子的研發和推出
      • 增加 API 生產外包
      • 不斷增長的老年人口
      • 慢性病患病率
    • 市場製約因素分析
      • 生物製品的出現
      • 高度依賴亞洲國家的生產
  • SWOT 分析：按因素（政治和法律、經濟和技術）
  • 行業分析：搬運工
  • 報銷和監管方案
  • 重大交易和戰略聯盟
    • 推出新產品
    • 獲取
    • 擴展名
    • 合作夥伴關係
    • 營銷和推廣

第 4 章。合成小分子 API 市場：競爭格局

  • 近期發展和影響分析：按主要市場進入者
    • Ansoff Matrix
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 競爭信息中心分析
  • 私人公司
    • 主要初創企業列表
  • Regional Network Map

第 5 章合成小分子原料藥市場：製造商業務分析

  • 合成小分子原料藥市場：製造商波動分析
  • 內部
  • 外包

第 6 章合成小分子 API 市場：應用業務分析

  • 合成小分子 API 市場：應用變化分析
  • 心髒病學
  • 腫瘤學
  • 中樞神經系統和神經病學
  • 骨科
  • 內分泌科
  • 呼吸內科
  • 腸胃科
  • 腎臟科
  • 眼科
  • 其他

第 7 章。合成小分子 API 市場：區域業務分析

  • 2021 年和 2030 年按國家/地區分列的市場份額分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章。合成小分子 API 市場：公司概況

  • 公司簡介
    • AbbVie, Inc.
      • 會社概要
      • 財務實績
      • 製品
      • 戰略的
    • Bristol-Myers Squibb Company
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Boehringer Ingelheim International GmbH
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Cipla Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Teva Pharmaceutical Industries Ltd.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Albemarle Corporation
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Viatris Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Aurobindo Pharma
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Sun Pharmaceutical Industries Ltd.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Dr. Reddy's Laboratories Ltd.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
  • 他主要企業

Product Code: GVR-4-68039-976-3

Synthetic Small Molecule API Market Growth & Trends:

The global synthetic small molecule API market size is expected to reach USD 217.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.73% from 2022 to 2030. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m2 for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Synthetic Small Molecule API Market Report Highlights:

  • The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material
  • The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk
  • By manufacturer, the outsourced segment is expected to witness lucrative growth over the forecast period owing to a dependency of small and mid-sized companies on outsourcing for commercial production
  • The cardiology appolication segment dominated the market in 2021. This is attributed to the increasing prevalence of target diseases
  • North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Table of Contents

Chapter 1 Synthetic Small Molecule API Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 Synthetic Small Molecule API Market: Executive Summary

  • 2.1 Synthetic Small Molecule API Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 Synthetic Small Molecule API Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 High growth of the pharmaceutical industry
      • 3.3.1.2 Rising R&D and launch of novel molecules
      • 3.3.1.3 Increased outsourcing of API production
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Escalating prevalence of chronic diseases
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Emergence of biologics
      • 3.3.2.2 High dependence on Asian nations for production
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Synthetic Small Molecule API Market: Competitive Landscape

  • 4.1 Recent developments & impact analysis, by key market participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Synthetic Small Molecule API Market: Manufacturer Business Analysis

  • 5.1 Synthetic Small Molecule API Market: Manufacturer Movement Analysis
  • 5.2 In-house
    • 5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion) (Volume, in Metric Tons)
  • 5.3 Outsourced
    • 5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)(Volume, in Metric Tons)

Chapter 6 Synthetic Small Molecule API Market: Application Business Analysis

  • 6.1 Synthetic Small Molecule API Market: Application Movement Analysis
  • 6.2 Cardiology
    • 6.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.3 Oncology
    • 6.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.4 CNS and Neurology
    • 6.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.5 Orthopedic
    • 6.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.6 Endocrinology
    • 6.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.7 Pulmonology
    • 6.7.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.8 Gastroenterology
    • 6.8.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.9 Nephrology
    • 6.9.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.10 Opthalmology
    • 6.10.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.11 Others
    • 6.11.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7 Synthetic Small Molecule API Market: Regional Business Analysis

  • 7.1 Market Share Analysis by Country, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.2 Europe
      • 7.1.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.2 U.K.
      • 7.1.2.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.4 France
      • 7.1.2.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.3 Asia Pacific
      • 7.1.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.3 China
      • 7.1.3.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.4 India
      • 7.1.3.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.5 South Korea
      • 7.1.3.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.3.6 Australia
      • 7.1.3.6.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.4 Latin America
      • 7.1.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
    • 7.1.5 Middle East & Africa
      • 7.1.5.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Market estimates and forecast, 2018 - 2030 (USD Billion)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 Market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 8 Synthetic Small Molecule API Market: Company Profiling

  • 8.1 Company Profiles
    • 8.1.1 AbbVie, Inc.
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Bristol-Myers Squibb Company
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Boehringer Ingelheim International GmbH
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Cipla Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Teva Pharmaceutical Industries Ltd.
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Albemarle Corporation
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 Viatris Inc.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Aurobindo Pharma
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 Sun Pharmaceutical Industries Ltd.
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 Dr. Reddy's Laboratories Ltd.
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial performance
      • 8.1.10.3 Product benchmarking
      • 8.1.10.4 Strategic initiatives
  • 8.2 List of Other Key Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global Synthetic Small Molecule API Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 6 Global Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 North America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 8 North America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 9 North America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 11 U.S. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 12 Canada Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 13 Canada Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 Europe Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 15 Europe Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 16 Europe Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Germany Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 18 Germany Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 U.K. Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 20 U.K. Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 21 France Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 22 France Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 23 Italy Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 24 Italy Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 25 Spain Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 26 Spain Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 Asia Pacific Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 29 Asia pacific Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 Japan Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 31 Japan Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 32 China Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 33 China Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 India Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 35 India Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 South Korea Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 37 South Korea Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 38 Australia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 39 Australia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Latin America Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 41 Latin America Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 42 Latin America Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 43 Brazil Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 44 Brazil Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Mexico Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 46 Mexico Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 47 Argentina Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 48 Argentina Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 49 Middle East & Africa Synthetic Small Molecule API Market, By Country, 2018 - 2030 (USD Billion)
  • Table 50 Middle East & Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 51 Middle East & Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 52 Saudi Arabia Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 53 Saudi Arabia Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 54 South Africa Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 55 South Africa Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 UAE Synthetic Small Molecule API Market, By Manufacturer, 2018 - 2030 (USD Billion)
  • Table 57 UAE Synthetic Small Molecule API Market, By Application, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Synthetic small molecule API market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Synthetic Small Molecule API market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, (USD Billion)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Synthetic small molecule API market driver impact
  • Fig. 14 Synthetic small molecule API market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Synthetic small molecule API market: manufacturer outlook and key takeaways
  • Fig. 19 Synthetic small molecule API market: manufacturer movement analysis & market share 2021 & 2030
  • Fig. 20 In-house market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Outsourced market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Synthetic small molecule API market: application outlook and key takeaways
  • Fig. 23 Synthetic small molecule API market: application movement analysis & market share 2021 & 2030
  • Fig. 24 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 CNS and Neurology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Orthopedic market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Small Molecule API: Regional outlook and key takeaways
  • Fig. 35 Regional outlook, 2021 & 2030
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe
  • Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 U.K.
  • Fig. 45 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Germany
  • Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 France
  • Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Italy
  • Fig. 51 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 Spain
  • Fig. 53 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 Asia Pacific
  • Fig. 55 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Japan
  • Fig. 57 Japan market estimates and forecast, 2018 - 2030(USD Billion)
  • Fig. 58 China
  • Fig. 59 China market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 India
  • Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 South Korea
  • Fig. 63 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Australia
  • Fig. 65 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Latin America
  • Fig. 67 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 68 Brazil
  • Fig. 69 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 70 Mexico
  • Fig. 71 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Argentina
  • Fig. 73 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 Middle East & Africa
  • Fig. 75 MEA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 76 South Africa
  • Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 78 Saudi Arabia
  • Fig. 79 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 80 UAE
  • Fig. 81 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 82 Ansoff Matrix
  • Fig. 83 Market differentiators
  • Fig. 84 Key company market share analysis, 2021
  • Fig. 85 Company market position analysis
  • Fig. 86 Competitive dashboard analysis
  • Fig. 87 Regional network map